Hemostats Market Analysis 2030
According to the report published by Allied Market Research, the global hemostats market generated $2.8 billion in 2021, and is projected to reach $4.7 billion by 2031, witnessing a CAGR of 5.3% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Increase in number of surgeries across various areas such as orthopedic, gynecology, reconstructive, and cardiac and rise in various types of cancer that require surgical procedures drive the growth of the global hemostats market. However, stringent government regulations associated with the approval of hemostats impede the market growth. Moreover, new innovations by key players and rise in number of product approvals for hemostasis products are expected to generate potential opportunities for the market during the forecast period.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/17218
Control of excessive bleeding during surgery is a difficult but important task. Products called hemostats can be placed on a bleeding sites during surgery to help the body’s own processes for clotting. It is used during early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats are look like rings scissors. Frequently hemostatic forceps have a locking mechanism called a ratchet, which is used for clamping. Hemostats such as absorbable gelatin sponge, collagen hemostat, and oxidized cellulose are commercially available.
Rise in prevalence of various types of surgeries, rising number of key players, and high adoption of hemostats product by hospitals and surgical centers drive the market growth, which are expected to notably contribute toward the growth of the global hemostats market during the forecast period.
Life Sciences at Allied Market Research
Market Segmentation
Based on type, the thrombin based hemostats segment was the largest in 2021, holding nearly one-fourth of the total market. However, the combination hemostats segment is estimated to register the highest CAGR of 6.6% from 2022 to 2031.
Based on formulation, the matrix and gel hemostats segment was the largest in 2021, grabbing more than one-fourth of the global market. However, the sheet and pad hemostats segment is projected to register the highest CAGR of 6.4% in 2031.
Based on region, North America contributed to more than two-fifths of the total market share in 2021 and is estimated to continue its dominancy through 2031. However, Asia-Pacific is projected to manifest the fastest CAGR of 7.1% during the forecast period. The other regions analyzed in the report are Europe and LAMEA.
Leading players of the global hemostats market analyzed in the research include Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson and Company, Hemostatis LLC, Integra Life Sciences Holding Corporation, Johnson and Johnson, Medtronic Plc, Pfizer Inc., Stryker Corporation, and Teleflex Incorporated.
Trending Reports in Healthcare Industry-
Mechanical Ventilator Market to Reach $18.63 Bn, Globally, by 2030 at 12.8% CAGR
Global Immunoassay Market Poised for Strong Growth Through 2033 | $61.6 Billion by 2033
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
